---
title: "The See-Through Gel in Your Eye: Why It Matters More Than You Think!"
description: "Discover why the vitreous gel in your eye matters, how it changes with age, and the latest advances in hydrogel substitutes designed to better mimic its structure, mechanics, and antioxidant functions."
tags: [eye, vitreous, hydrogel, biomaterials, aging, antioxidants, biotransport]
---

## The See-Through Gel in Your Eye: Why It Matters More Than You Think!

Featured paper: [**Macro- and Microscale Properties of the Vitreous Humor to Inform Substitute Design and Intravitreal Biotransport**](https://doi.org/10.1080/02713683.2020.1826977)

*Disclaimer: This content was generated by AI and has been reviewed for accuracy by Dr. Tram.*

Today, let's continue our deep dive into a fascinating part of your eye: the vitreous humor. It's that gel-like substance filling the space between your eye's lens and retina, making up a whopping 80% of your eye's volume. Imagine a soft, transparent gel that acts like a cushion, holding everything in place and protecting those delicate tissues from bumps and jolts. But the vitreous is more than just a physical buffer. It also plays a crucial biochemical role, helping to maintain a specific oxygen balance inside your eye. It does this partly through its gel structure, which limits oxygen movement by convection, and partly by containing antioxidants like vitamin C (ascorbic acid) that consume oxygen. This creates a gradient where there's high oxygen near the retina (which is very active) and low oxygen near the lens (which is sensitive to oxygen damage). This balance is super important for the health of your eye's tissues.

**The Challenge of an Aging Vitreous**

While the vitreous is amazing, it doesn't last forever in its original state. As we age, it undergoes changes. The homogeneous gel starts to break down and separate into two phases: stiffer areas with clumps of collagen fibers and pockets of watery liquid where the hyaluronic acid has separated. Think of it like an old gel that starts to clump and get watery in spots. This process is called liquefaction and is influenced by factors like oxidative damage and the degradation of certain collagen types.

This age-related breakdown isn't just a minor change; it can lead to significant eye problems. When the vitreous liquefies, it can pull away from the retina, sometimes creating areas of high stress where they are still attached. This traction can cause retinal tears, macular holes, or even lead to a serious condition called retinal detachment where the retina pulls away from the back of the eye. The liquid pockets can also cause "floaters," those annoying shadows you sometimes see, which are just clumps of aggregated fibers floating in the liquefied vitreous casting shadows on the retina. Furthermore, the altered structure of the aging vitreous messes up that crucial oxygen gradient, exposing the lens to more oxygen and potentially contributing to cataract formation.

<!-- Podcast embed -->
<div align="center">
  <iframe width="100%" height="315" src="https://www.youtube.com/embed/DK8y1QghJ6M?si=yoxWUhfDkAWFg5qR" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>

Scientists are keen to understand how the vitreous's properties change with age. However, studying these changes, especially in humans, has been tricky, partly due to the difficulty in getting young donor tissue. Early studies using techniques like ultrasound or light scattering didn't find clear age-related differences. A breakthrough came with studies using shear rheology, a technique that measures how a material responds to shearing forces, giving insight into its solid-like (elastic, G') and liquid-like (viscous, G'') qualities. [One study that tested the separated solid and liquid phases of human vitreous found that the gel phase actually became stiffer with age, while the liquid phase became less elastic.](https://nguyenktram.com/2025/05/14/The-Jell-O-of-Your-Eye.html) This seems contradictory to other studies that found the overall dynamic moduli (storage and loss) of the *whole* vitreous decreased with age. This difference likely stems from how the tests were done; testing the entire sample including the liquid pockets of an older eye makes the whole thing seem softer, even if the remaining gel is stiffer.

**The Need for Vitreous Substitutes**

When serious issues like retinal detachment occur, surgery (vitrectomy) is often necessary. This involves removing the damaged vitreous humor and replacing it with a substitute. The substitutes currently used, like silicone oil, saline solutions, or gases, are usually temporary placeholders. They provide tension to hold the retina in place while it heals, but they have significant drawbacks, especially for long-term use.

Silicone oil, often considered the standard for long-term substitution despite its issues, is hydrophobic, meaning it doesn't mix well with the eye's natural fluid (aqueous humor). This can lead to it emulsifying (breaking into small droplets) or getting trapped in the eye's drainage system, potentially causing inflammation or glaucoma. Also, because silicone oil floats, patients often have to spend time in uncomfortable face-down positions to keep the oil in contact with the retina. Remember that vital oxygen gradient the natural vitreous maintains? Silicone oil is much more permeable to oxygen than water, flattening this gradient and potentially increasing the risk of cataracts. Clearly, there's a strong need for better materials to replace the vitreous.

**Hydrogels: A Promising Avenue**

Enter hydrogels! These materials, which are essentially networks of polymers swollen with water, have emerged as promising candidates for vitreous substitutes because they are hydrophilic (water-loving), mimicking the high water content of the natural vitreous. Research into hydrogel vitreous substitutes has increased significantly alongside studies on the vitreous humor itself, especially in the last two decades.

Scientists are exploring different types of hydrogels: synthetic, semisynthetic, and natural. Synthetic and semisynthetic hydrogels have become more common in recent research compared to natural hydrogels that were more prevalent in earlier studies. Another interesting approach is the Foldable Capsular Vitreous Body (FCVB), a polymeric bag implanted and filled with a substance like saline or silicone oil. The FCVB is currently undergoing clinical trials in China and is arguably closest to clinical use among experimental substitutes.

When designing these substitutes, a key goal is **biomimicry** – making the substitute behave as much like the natural vitreous as possible. This includes matching its mechanical properties. However, most experimental hydrogel substitutes developed so far are much stiffer than the native human vitreous. Their storage and loss moduli are often orders of magnitude higher. Natural hydrogels tend to be softer than synthetic or semisynthetic ones, but still generally stiffer than human vitreous. Hydrogels designed for direct injection into the eye or those that gel in situ (crosslinking) or in response to temperature changes (thermogelling) also show a wide range of stiffness, though some direct injection and thermogelling/in situ crosslinking hydrogels have moduli closer to the human vitreous than others. Only a small number of experimental hydrogels (n=13 mentioned) have reported moduli similar to the reported values for human vitreous (less than 20 Pa). It's unknown if the high stiffness of many substitutes could cause long-term harm to eye tissues.

**The Challenge of Measurement**

One of the biggest hurdles in developing perfect vitreous substitutes is accurately knowing the mechanical properties of the *native* human vitreous *in vivo* (in the living eye). As mentioned, studies on dissected vitreous samples in the lab (in vitro) face a problem: the vitreous changes rapidly after removal and dissection, disrupting its structure and causing liquid to expel within minutes. This means measurements on dissected samples are likely different, probably lower, than in the intact eye.

Scientists are working on techniques to measure vitreous properties in situ (in its natural place but often in a removed eye) or in vivo. Some involve minimally invasive methods like creep testing with probes or cavitation rheology, which aim to keep the vitreous structure mostly intact. Non-invasive techniques like MRI, ultrasound, and light scattering can study the vitreous in living eyes. However, a major challenge is that these non-invasive techniques often measure different properties or don't provide data (like storage and loss moduli) that can be directly compared to the standard rheological measurements used for hydrogels and dissected vitreous samples. For instance, one technique called Brillouin spectroscopy reported moduli for pig vitreous that were six orders of magnitude higher than values from shear rheology. More research is needed to improve in vivo measurement techniques and find ways to compare data across different methods.

**Beyond Mechanics: Biotransport and Therapeutics**

A perfect vitreous substitute needs to do more than just fill the space and have the right squishiness. It also needs to allow important molecules to move through it properly – this is called biotransport. This is critical for drug delivery (many eye medicines are injected directly into the vitreous) and for maintaining the eye's internal environment, including the antioxidant balance and the oxygen gradient.

The structure of the vitreous, especially how it changes with age and liquefaction, significantly affects how molecules diffuse through it. Studies have shown that liquefied human vitreous allows faster diffusion of molecules compared to presumably intact animal vitreous, even if their overall mechanical properties measured in vitro seemed similar. This highlights the importance of understanding microscale properties (like the size of the gaps in the gel network) and how they relate to transport.

[An exciting area of research is incorporating therapeutic drugs directly into vitreous substitutes.](https://nguyenktram.com/2025/05/21/A-Gel-That-Heals.html). Imagine a substitute that not only supports the retina but also slowly releases medication to treat an ongoing disease! The FCVB, for example, with its capsule, has been used to release various drugs. Hydrogels are also being developed to deliver drugs, like microspheres containing medicine for certain retinal conditions.

Another promising strategy is designing hydrogel substitutes that release antioxidants, like vitamin C or glutathione. Since vitreous liquefaction is linked to increased oxidative damage and cataracts, a substitute that helps restore the antioxidant environment could potentially prevent these complications after surgery. [Recent work shows that combining antioxidants like glutathione and vitamin C in a hydrogel can protect lens cells from damage.](https://nguyenktram.com/2025/05/28/Protecting-Your-Peepers.html)

**Looking Ahead**

Research on the vitreous humor and the development of substitutes has made huge strides, especially in the last two decades. We've learned a lot about its structure, function, and how it changes with age. We know that animal models, particularly pig and rabbit vitreous, have mechanical properties most similar to human vitreous (when measured in vitro) and are good models for future studies.

However, key challenges remain. We desperately need better ways to measure the mechanical and transport properties of the vitreous *inside* the living eye. This will give us a clearer target for designing truly biomimetic substitutes that match the native tissue's behavior. While many experimental hydrogels are currently much stiffer than the human vitreous, the focus is shifting towards creating substitutes that are not only mechanically similar but also perform the vital biochemical functions of the natural vitreous, such as maintaining the antioxidant balance and regulating biotransport.

The future of vitreous substitutes lies in a holistic approach that considers both the physical support and the complex biological environment of the eye. Drug-eluting and antioxidant-releasing hydrogels represent a new generation of materials that could revolutionize how we treat vitreoretinal diseases, potentially improving patient outcomes and quality of life after surgery. It's an exciting time where engineers, scientists, and doctors are working together to solve these complex challenges!